NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR PERSONS CLOSELY ASSOCIATED WITH THEM
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||||||
|
a)
|
|
|
|||||||||
|
2
|
Reason for the notification
|
||||||||||
|
a)
|
Position/status
|
Person closely associated with |
|||||||||
|
b)
|
Initial notification /Amendment
|
Initial |
|||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
||||||||||
|
a)
|
|
|
|||||||||
|
b)
|
LEI
|
213800LRO7NS5CYQMN21 |
|||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in
ISIN: GB0030913577
|
|||||||||
|
b)
|
Nature of the transaction
|
(1) Novation of existing cash-settled derivatives transactions relating to the Issuer's ordinary shares entered into by (2) Pledge of Issuer ordinary shares to secure The extent of |
|||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
150,000,000 ordinary shares of the issuer referenced by the novated derivatives.
N/A
|
|||||||||
|
e)
|
Date of the transaction
|
|
|||||||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||||||||
Enquiries
|
Press office: |
|
||
|
|
Tel: +44 7734 776 317 Tel: +44 7496 691845 |
||
|
|
||
|
Investor relations: |
|
||
|
Nick Delfas |
Tel: 0800 389 4909 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the